ADCETRIS subst sèche 50 mg flac 2 pce
7680621320034
CH-62132
L01FX05
07.16.1.
Reimbursement limitations:
ADCETRIS.01
Lymphome hodgkinien (LH)
LH (Stade IV), thérapie combinée (avec modèle de prix)
Remboursement pour le …
1 / 3
google
Details
- Product number
- 6213201
- CPT
- -
- Packaging group
- 2
- Unit
- Durchstechflasche(n)
- Composition
- Praeparatio cryodesiccata: brentuximabum vedotinum 50 mg, acidum citricum monohydricum, natrii citras dihydricus, trehalosum dihydricum, polysorbatum 80, pro vitro, natrium 13.2 mg.
Articles (1)
Adcetris, Pulver für ein Konzentrat zur Herstellung einer Infusionslösung
Pulver für ein Konzentrat zur Herstellung einer Infusionslösung
2
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
PRC
|
50.0 MG | Substance | Wirkstoff (Principe actif) |
|
PRC
|
- | Substance | HNIDK |
|
PRC
|
- | Substance | HNIDK |
|
PRC
|
- | Substance | HNIDK |
|
PRC
|
- | Substance | HNIDK |
|
PRC
|
13.2 MG | Substance | HBESI |
Reimbursement information
Public price
CHF 6434.85
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/11/2014
Authorization holder
Takeda Pharma AG
8152 Opfikon
Authorization information
- Swissmedic authorization number
- 62132
- Drug name
- Adcetris, Pulver für ein Konzentrat zur Herstellung einer Infusionslösung
- Galenic form
- PULPI
- ATC Code
- L01FX05
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 04/03/2013
- Authorization expiration date
- 31/12/9999
- IT number
- 07.16.1.
- Domain
- Human medicine
Packaging details
- Description (FR)
- ADCETRIS subst sèche 50 mg flac 2 pce
- Description (DE)
- ADCETRIS Trockensub 50 mg Durchstf 2 Stk
- Market launch
- 04/03/2013
- Narcotic (BTM)
- No